UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

P.08.8: Silybin in Combination with Regorafenib as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer Patients

Digestive and liver disease, 2017-03, Vol.49, p.e181-e182

2017

Volltextzugriff (PDF)

P.01.4 ENDOCAN AS SERUM MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND/OR TYPE 2 DIABETES

Digestive and liver disease, 2016-02, Vol.48, p.e131-e131

2016

Volltextzugriff (PDF)

P.14.5 THE ROLE OF HELICOBACTER PYLORI INFECTION AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN ROSACEA

Digestive and liver disease, 2014-03, Vol.46, p.S110-S110

2014

Volltextzugriff (PDF)

P.06.24 GENDER DIFFERENCE IN DERMATOLOGICAL ADVERSE EFFECTS DURING ANTIBODIES ANTI-TNF ALFA THERAPY IN CHRONIC INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2014-03, Vol.46, p.S78-S78

2014

Volltextzugriff (PDF)

P.17.9 TELAPREVIR- OR BOCEPREVIR-BASED TRIPLE-THERAPY IN PATIENTS WITH HCV INFECTION GENOTYPE 1: ON-TREATMENT EFFICACY AND DATA ON SAFETY

Digestive and liver disease, 2014-03, Vol.46, p.S123-S123

2014

Volltextzugriff (PDF)

Gastric xanthomatosis associated with gastric intestinal metaplasia in a dyspeptic patient

Digestive and liver disease, 2009-10, Vol.41 (10), p.765-765

2009

Volltextzugriff (PDF)

Ulcerative colitis associated with leukocytoclastic vasculitis of the skin

Digestive and liver disease, 2009-07, Vol.41 (7), p.e42-e44

2009

Volltextzugriff (PDF)

P.03.3 PEPTIDE HP 2-20 ACCELERATED HEALING OF TNBS-INDUCED COLITIS IN THE RAT

Digestive and liver disease, 2013-03, Vol.45, p.S105-S106

2013

Volltextzugriff (PDF)

P.01.13 DOES GENDER INFLUENCE UPPER GASTROINTESTINAL SYMPTOMS AND ENDOSCOPIC DIAGNOSIS?

Digestive and liver disease, 2012-03, Vol.44, p.S93-S93

2012

Volltextzugriff (PDF)

P.1.123: LEVOFLOXACIN-CONTAINING QUADRUPLE CONCOMITANT THERAPY FOR ERADICATION OF H PYLORI INFECTION

Digestive and liver disease, 2011, Vol.43, p.S188-S189

2011

Volltextzugriff (PDF)

T.04.8: IBD PATIENTS SHOW WORRYING LEVELS OF SELF-REPORTED PHYSICAL INACTIVITY AS MEASURED BY THE INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE INDEPENDENTLY OF DISEASE ACTIVITY AND IBD PHENOTYPE: RESULTS FROM THE EXTENDED “BE-FIT-IBD” CROSS-SECTIONAL STUDY

Digestive and liver disease, 2024-04, Vol.56, p.S240-S241

2024

Volltextzugriff (PDF)

BOC.01.12: MELANOCORTIN 3 AND 5 RECEPTORS ARE EXPRESSED IN THE COLON OF INFLAMMATORY BOWEL DISEASE PATIENTS AND SHOWA DIFFERENT IMMUNOHISTOCHEMICAL PROFILE THAT ACCOUNTS FOR INFLAMMATORY INVOLVEMENT IN THE COLON: THE EMERGENCE OF A NEW THERAPEUTIC TARGET?

Digestive and liver disease, 2024-04, Vol.56, p.S107-108

2024

Volltextzugriff (PDF)

OC.03.3: CAN CHAT GENERATIVE PRE-TRAINED TRANSFORMER (CHATGPT) BE AN AI-PROVIDED FRIEND OF THE IBD PATIENTS FOR FREQUENTLY ASKED QUESTIONS RELATED TO THEIR DISEASE MANAGEMENT? AN EVIDENCE- AND GUIDELINESCONTROLLED TEXTUAL ANALYSIS OF AI-PROVIDED OUTPUTS

Digestive and liver disease, 2024-04, Vol.56, p.S134-S135

2024

Volltextzugriff (PDF)

T.07.1: PREVALENCE OF DYSGEUSIA IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE (ACLD), RELATIONSHIP WITH THE LIVER-DISEASE PROGRESSION STATUS, AND IMPACT ON MALNUTRITION-SARCOPENIA-FRAILTY (THE PREDYCI STUDY)

Digestive and liver disease, 2024-04, Vol.56, p.S253-S254

2024

Volltextzugriff (PDF)

OC.02.3 FOURTEEN-DAY, HIGH-DOSE ACID SUPPRESSION, NON-BISMUTH QUADRUPLE THERAPIES (“HYBRID” VS. “CONCOMITANT”) FOR HELICOBACTER PYLORI ERADICATION: A RANDOMISED TRIAL

Digestive and liver disease, 2013-03, Vol.45, p.S61-S61

2013

Volltextzugriff (PDF)

P.08.6 UROTENSIN-II RECEPTOR: A NEW MARKER FOR THE DIFFERENTIATION AND THE TARGET IN COLON CANCER?

Digestive and liver disease, 2012-03, Vol.44, p.S136-S136

2012

Volltextzugriff (PDF)

AF.86 THE ANALYSIS OF ALCOHOL CONSUMPTION DURING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ITALIAN LOCKDOWN

Digestive and liver disease, 2021-09, Vol.53, p.S176-S177

2021

Volltextzugriff (PDF)

Hashimoto's Thyroiditis and Entero-Chromaffin-like Cell Hyperplasia: Early Detection and Somatostatin Analogue Treatment

European journal of inflammation, 2013-09, Vol.11 (3), p.863-870

2013

Volltextzugriff (PDF)

P.28 LEVOFLOXACIN-BASED SEQUENTIAL THERAPY VS CLARITHROMYCIN-BASED SEQUENTIAL THERAPY FOR ERADICATION OF H. PYLORI INFECTION

Digestive and liver disease, 2010, Vol.42, p.S112-S113

2010

Volltextzugriff (PDF)

T.03.8 SEXUAL DYSFUNCTION IN PATIENTS WITH COELIAC DISEASE: A CROSS-SECTIONAL STUDY

Digestive and liver disease, 2022-05, Vol.54, p.S127-S127

2022

Volltextzugriff (PDF)

T06.01.16 EVALUATION OF THE EFFECT DERIVED FROM SILYBIN WITH VITAMIN D AND 3 VITAMIN E ADMINISTRATION ON CLINICAL, METABOLIC, ENDOTHELIAL 4 DYSFUNCTION, OXIDATIVE STRESS PARAMETERS AND SEROLOGICAL WORSENING 5 MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS

Digestive and liver disease, 2020-10, Vol.52, p.S165

2020

Volltextzugriff (PDF)

T06.01.9 THE BISPHENOL A INDUCED WORSENING OF NON-ALCOHOLIC FATTY LIVER DISEASE: A CLINICAL STRATEGY TO ANTAGONIZE THE PROGRESSION OF THE DISEASE

Digestive and liver disease, 2020-10, Vol.52, p.S161-S162

2020

Volltextzugriff (PDF)

P.09.18 DIETARY INTAKE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: QUALITATIVE AND QUANTITATIVE EVALUATION

Digestive and liver disease, 2018-03, Vol.50 (2), p.e223-e223

2018

Volltextzugriff (PDF)

AF.54 EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: AN OBSERVATIONAL REAL-LIFE STUDY

Digestive and liver disease, 2021-09, Vol.53, p.S161

2021

Volltextzugriff (PDF)

PO.5 INTRAFAMILIAL SPREAD OF HELICOBACTER PYLORI INFECTION

Digestive and liver disease, 2008, Vol.40, p.S172-S172

2008

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Kollektion

Ingenta
(36)
Access via ScienceDirect (Elsevier)
(36)
IngentaConnect Journals
(14)
MEDLINE
(2)
Oxford journals
(1)
Oxford Journals 2020 Medicine
(1)
EZB Electronic Journals Library
(1)
Journals@Ovid Ovid Full Text
(1)
SAGE Journals Online
(1)

4 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

P.08.8: Silybin in Combination with Regorafenib as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer Patients

P.01.4 ENDOCAN AS SERUM MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND/OR TYPE 2 DIABETES

P.14.5 THE ROLE OF HELICOBACTER PYLORI INFECTION AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN ROSACEA

P.06.24 GENDER DIFFERENCE IN DERMATOLOGICAL ADVERSE EFFECTS DURING ANTIBODIES ANTI-TNF ALFA THERAPY IN CHRONIC INFLAMMATORY BOWEL DISEASE

P.17.9 TELAPREVIR- OR BOCEPREVIR-BASED TRIPLE-THERAPY IN PATIENTS WITH HCV INFECTION GENOTYPE 1: ON-TREATMENT EFFICACY AND DATA ON SAFETY

Gastric xanthomatosis associated with gastric intestinal metaplasia in a dyspeptic patient

Ulcerative colitis associated with leukocytoclastic vasculitis of the skin

P.03.3 PEPTIDE HP 2-20 ACCELERATED HEALING OF TNBS-INDUCED COLITIS IN THE RAT

P.01.13 DOES GENDER INFLUENCE UPPER GASTROINTESTINAL SYMPTOMS AND ENDOSCOPIC DIAGNOSIS?

P.1.123: LEVOFLOXACIN-CONTAINING QUADRUPLE CONCOMITANT THERAPY FOR ERADICATION OF H PYLORI INFECTION

T.04.8: IBD PATIENTS SHOW WORRYING LEVELS OF SELF-REPORTED PHYSICAL INACTIVITY AS MEASURED BY THE INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE INDEPENDENTLY OF DISEASE ACTIVITY AND IBD PHENOTYPE: RESULTS FROM THE EXTENDED “BE-FIT-IBD” CROSS-SECTIONAL STUDY

BOC.01.12: MELANOCORTIN 3 AND 5 RECEPTORS ARE EXPRESSED IN THE COLON OF INFLAMMATORY BOWEL DISEASE PATIENTS AND SHOWA DIFFERENT IMMUNOHISTOCHEMICAL PROFILE THAT ACCOUNTS FOR INFLAMMATORY INVOLVEMENT IN THE COLON: THE EMERGENCE OF A NEW THERAPEUTIC TARGET?

OC.03.3: CAN CHAT GENERATIVE PRE-TRAINED TRANSFORMER (CHATGPT) BE AN AI-PROVIDED FRIEND OF THE IBD PATIENTS FOR FREQUENTLY ASKED QUESTIONS RELATED TO THEIR DISEASE MANAGEMENT? AN EVIDENCE- AND GUIDELINESCONTROLLED TEXTUAL ANALYSIS OF AI-PROVIDED OUTPUTS

T.07.1: PREVALENCE OF DYSGEUSIA IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE (ACLD), RELATIONSHIP WITH THE LIVER-DISEASE PROGRESSION STATUS, AND IMPACT ON MALNUTRITION-SARCOPENIA-FRAILTY (THE PREDYCI STUDY)

OC.02.3 FOURTEEN-DAY, HIGH-DOSE ACID SUPPRESSION, NON-BISMUTH QUADRUPLE THERAPIES (“HYBRID” VS. “CONCOMITANT”) FOR HELICOBACTER PYLORI ERADICATION: A RANDOMISED TRIAL

P.08.6 UROTENSIN-II RECEPTOR: A NEW MARKER FOR THE DIFFERENTIATION AND THE TARGET IN COLON CANCER?

AF.86 THE ANALYSIS OF ALCOHOL CONSUMPTION DURING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ITALIAN LOCKDOWN

Hashimoto's Thyroiditis and Entero-Chromaffin-like Cell Hyperplasia: Early Detection and Somatostatin Analogue Treatment

P.28 LEVOFLOXACIN-BASED SEQUENTIAL THERAPY VS CLARITHROMYCIN-BASED SEQUENTIAL THERAPY FOR ERADICATION OF H. PYLORI INFECTION

T.03.8 SEXUAL DYSFUNCTION IN PATIENTS WITH COELIAC DISEASE: A CROSS-SECTIONAL STUDY

T06.01.16 EVALUATION OF THE EFFECT DERIVED FROM SILYBIN WITH VITAMIN D AND 3 VITAMIN E ADMINISTRATION ON CLINICAL, METABOLIC, ENDOTHELIAL 4 DYSFUNCTION, OXIDATIVE STRESS PARAMETERS AND SEROLOGICAL WORSENING 5 MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS

T06.01.9 THE BISPHENOL A INDUCED WORSENING OF NON-ALCOHOLIC FATTY LIVER DISEASE: A CLINICAL STRATEGY TO ANTAGONIZE THE PROGRESSION OF THE DISEASE

P.09.18 DIETARY INTAKE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: QUALITATIVE AND QUANTITATIVE EVALUATION

AF.54 EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: AN OBSERVATIONAL REAL-LIFE STUDY

PO.5 INTRAFAMILIAL SPREAD OF HELICOBACTER PYLORI INFECTION

Suchergebnisse filtern